Ferreira Bulhosa L et al., 2020-05: Prospective study in 41 dogs with transmissible venereal tumour (20 randomised to treatment) finding that adding ivermectin to vincristine gave similar time to remission but less chemotherapy-induced neutropenia than vincristine alone.
Although dogs in the G-Iv/Vin group had more severe disease at the beginning of the study (P = 0.0031), the number of weeks and chemotherapy sessions until tumor remission were similar among dogs of the two groups, indicating both treatments were effective.
n/a (PubMed abstract)
Ferreira Bulhosa L et al., 2020-05: Prospective study in 41 dogs with transmissible venereal tumour (20 randomised to treatment) finding that adding ivermectin to vincristine gave similar time to remission but less chemotherapy-induced neutropenia than vincristine alone. Study type: prospective veterinary clinical study with random allocation of 20 dogs (10 vincristine, 10 vincristine plus ivermectin). N: 41 characterised, 20 treated. Country: Brazil (Federal University of Bahia, Salvador). Dose: ivermectin dose not stated in the abstract; vincristine standard regimen. Funder: not stated. Declared COI: 'There are no conflicts of interest to report.' Comparator: vincristine alone. PARTLY SUPPORTS: no added antitumour benefit was shown over vincristine alone, but toxicity was lower. Study type: randomized trial.
